Nitric oxide decreases expression of osmoprotective genes via direct inhibition of TonEBP transcriptional activity.
During antidiuresis, renal medullary cells adapt to the hyperosmotic interstitial environment by increased expression of osmoprotective genes, which is driven by a common transcriptional activator, tonicity-responsive enhancer binding protein (TonEBP). Because nitric oxide (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and TonEBP activation in MDCK cells. Several structurally unrelated NO donors blunted tonicity-induced up-regulation of TonEBP target genes involved in intracellular accumulation of organic osmolytes. These effects were mediated by reduced transcriptional activity of TonEBP, as assessed by tonicity-responsive elements- and aldose reductase promoter-driven reporter constructs. Neither total TonEBP abundance nor nuclear translocation of TonEBP was affected by NO. Furthermore, 8-bromo-cGMP and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on TonEBP rather than through classical NO signaling pathways. In support of this notion, electrophoretic mobility shift assays showed reduced binding of TonEBP to its target sequence in nuclear extracts prepared from MDCK cells treated with NO in vivo and in nuclear extracts exposed to NO in vitro. Furthermore, immunoprecipitation of S-nitrosylated proteins and the biotin-switch method identified TonEBP as a target for S-nitrosylation, which correlates with reduced DNA binding and transcriptional activity. These observations disclose a novel direct inhibitory effect of NO on TonEBP, a phenomenon that may be relevant for regulation of osmoprotective genes in the renal medulla.
Neuhofer
Wolfgang
W
Department of Physiology, University of Munich, Pettenkoferstrasse 12, 80336, Munich, Germany. Wolfgang.Neuhofer@med.uni-muenchen.de
Fraek
Maria-Luisa
ML
Beck
Franz-X
FX
D021581:Active Transport, Cell Nucleus / Q000502:physiology; D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000378:metabolism; D004285:Dogs; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D050778:NFATC Transcription Factors / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000378:metabolism; D030421:Peroxynitrous Acid / Q000378:metabolism; D014158:Transcription, Genetic; D014882:Water-Electrolyte Balance / Q000235:genetics*
D050778:NFATC Transcription Factors; D020030:Nitric Oxide Donors; D030421:Peroxynitrous Acid; C016276:8-bromocyclic GMP; D009569:Nitric Oxide; D006152:Cyclic GMP